Versant Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Versant Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.7K	Buy	936 +328	+54%	+$7.22K	﹤0.01%	1851
2026 Q1	$13.5K	Buy	608 +72	+13%	+$1.72K	﹤0.01%	2004
2025 Q4	$14.3K	Sell	536 -192	-26%	-$4.59K	﹤0.01%	1832
2025 Q3	$15.5K	Hold	728	–	–	﹤0.01%	1718
2025 Q2	$15.7K	Sell	728 -43	-6%	-$799	﹤0.01%	1658
2025 Q1	$12.8K	Buy	771 +235	+44%	+$4.27K	﹤0.01%	1591
2024 Q4	$9.84K	Buy	+536	New	+$8.65K	﹤0.01%	1408
2023 Q4	–	Sell	-24	Closed	-$500	–	1913
2023 Q3	$500	Hold	24	–	–	﹤0.01%	1693
2023 Q2	$575	Buy	+24	New	+$533	﹤0.01%	1797
2023 Q1	–	Sell	-49	Closed	-$780	–	1767
2022 Q4	$780	Hold	49	–	–	﹤0.01%	1357
2022 Q3	$1K	Buy	+49	New	+$794	﹤0.01%	1169
2021 Q4	–	Sell	-22	Closed	–	–	1414
2021 Q3	$0	Sell	22 -114	-84%	-$2.2K	﹤0.01%	1427
2021 Q2	$3K	Buy	+136	New	+$3.07K	﹤0.01%	1013
2021 Q1	–	Sell	-31	Closed	-$1K	–	1501
2020 Q4	$1K	Sell	31 -6	-16%	-$298	﹤0.01%	1177
2020 Q3	$1K	Hold	37	–	–	﹤0.01%	1136
2020 Q2	$1K	Hold	37	–	–	﹤0.01%	1131
2020 Q1	$1K	Buy	+37	New	+$1.52K	﹤0.01%	1087

Other funds holding ACAD

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Versant Capital Management's ACAD Position: Q2 2026 in Review

Versant Capital Management increased its Acadia Pharmaceuticals (ACAD) stake by 54% in Q2 2026, buying an estimated $7.22K and bringing the position to 936 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Versant Capital Management first reported a position in ACAD in Q1 2020 and has held it in 17 quarters since. 31 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Versant Capital Management held 936 shares of Acadia Pharmaceuticals worth $23.7K as of Q2 2026.
Versant Capital Management bought 328 Acadia Pharmaceuticals shares in Q2 2026, an estimated $7.22K.
Acadia Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1851 holding.
Versant Capital Management first reported a position in Acadia Pharmaceuticals in Q1 2020 and has held it in 17 quarters since.
31 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.